Oral Session 1-7B Malignant Lymphoma: Clinical Trials and Observation Studies

[OS1-7B-3] Long-term outcomes after R-CHOP for newly diagnosed advanced follicular lymphoma: JCOG0203

Nobuko Kubota¹, Takashi Watanabe^2,18, Kensei Tobinai², Masashi Wakabayashi³, Yasuo Morishima⁴, Tomohiro Kinoshita⁵, Kohsuke Asagoe⁶, Motoko Yamaguchi⁷, Kiyoshi Ando⁸, Michinori Ogura⁹, Masafumi Taniwaki¹⁰, Naokuni Uike¹¹, Tadashi Yoshino¹², Shigeru Nawano¹³, Takashi Terauchi¹⁴, Tomomitsu Hotta¹⁵, Kunihiro Tsukasaki¹⁶, Hirokazu Nagai¹⁷ (1.Hematol., Saitama Cancer Center, Ina, Saitama, Japan, 2.Hematol., National Cancer Center Hosp., Tokyo, Japan, 3.JCOG Data Center, National Cancer Center, Tokyo, Japan, 4.Hematol. and Cell Therapy, Aichi Cancer Center, Nagoya, Japan, 5.Hematol. and Oncol., Nagoya Univ., Nagoya, Japan, 6.Hematol. and Oncol., Shiga General Hosp., Moriyama, Japan, 7.Hematol. and Oncol., Mie Univ., Tsu, Japan, 8.Hematol. and Oncol., Tokai Univ., Kanagawa, Japan, 9.Hematol. and Oncol., Nagoya Daini Red Cross Hosp., Nagoya, Japan, 10.Hematol. and Oncol., Kyoto Pref. Univ., Kyoto, Japan, 11.Hematol., Kyusyu Cancer Center, Fukuoka, Japan, 12.Pathol., Okayama Univ., Okayama, Japan, 13.Radiol., International Univ. of Health and Welfare, Tokyo, Japan, 14.Nuclear Med., Cancer Institute Hosp., Tokyo, Japan, 15.NHO Nagoya Medical Center, Nagoya, Japan, 16.Hematol., National Cancer Center Hosp. East, Kashiwa, Japan, 17.Hematol., NHO Nagoya Medical Center, Nagoya, Japan, 18.Immuno-Gene Therapy, Mie Univ., Tsu, Japan)